{
 "drug": "Podofilox Topical Gel",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/28/2026",
 "dayN": 209,
 "cat": "Dermatology",
 "companies": [
  "AbbVie Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/28/2026",
   "update_type": "New",
   "initial_posting_date": "01/28/2026",
   "package_ndc": "0023-6118-03",
   "generic_name": "Podofilox Topical Gel",
   "contact_info": "800-633-9110",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020529"
    ],
    "brand_name": [
     "CONDYLOX"
    ],
    "generic_name": [
     "PODOFILOX"
    ],
    "manufacturer_name": [
     "Allergan, Inc."
    ],
    "product_ndc": [
     "0023-6118"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "TOPICAL"
    ],
    "substance_name": [
     "PODOFILOX"
    ],
    "rxcui": [
     "312466",
     "351750"
    ],
    "spl_id": [
     "9f2892be-8330-4fd1-930e-b4d204df4e03"
    ],
    "spl_set_id": [
     "032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37"
    ],
    "package_ndc": [
     "0023-6118-03"
    ],
    "nui": [
     "N0000008732"
    ],
    "pharm_class_pe": [
     "Decreased Mitosis [PE]"
    ],
    "unii": [
     "L36H50F353"
    ]
   },
   "update_date": "01/28/2026",
   "therapeutic_category": [
    "Dermatology",
    "Other"
   ],
   "dosage_form": "Topical Gel",
   "presentation": "Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)",
   "company_name": "AbbVie Inc.",
   "status": "To Be Discontinued"
  }
 ]
}